ICI IS LAUNCHING GENERIC ATENOLOL AT A 16.7% DISCOUNT FROM TENORMIN BRAND LIST PRICE; IPR SEPARATE VERSION ANTICIPATES SEPTEMBER 17 PATENT EXPIRATION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".